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CARDIOLOGY

Squamous Cell Carcinoma Metastatic to the Heart
Mimicking ST-Elevation Myocardial Infarction
Jason Chen, MD, Colin Craft, MD, Andrew Panakos, MD, Gregary D. Marhefka, MD, FACC, FACP

INTRODUCTION

DIFFERENTIAL DIAGNOSIS

Heart disease remains the leading cause of mortality in
the United States, accounting for about one quarter of all
deaths in 20131. Acute ischemic heart disease is a major
subpopulation of this group, and typically presents with
characteristic electrocardiographic (EKG) changes. The
most concerning of these findings are ST-elevations, as
ST Elevation Myocardial Infarction (STEMI) typically
indicates the need for emergent reperfusion therapy
because 30-day mortality of untreated STEMI is
approximately 10-15% versus 5% in treated cases2. As a
result, clinicians are taught to recognize the symptoms
and signs of myocardial ischemia and STEMI in order to
achieve timely reperfusion either via thrombolytic therapy
within 30 minutes or percutaneous coronary intervention
within 90 minutes.

The differential diagnosis for ST-elevation includes STEMI,
aortic dissection, pulmonary embolism, stress (takotsubo)
cardiomyopathy, pericarditis with or without effusion,
myocarditis, hypercalcemia, hyperkalemia, coronary
vasospasm, coronary artery dissection, left ventricular
aneurysm, left ventricular hypertrophy, the Brugada
syndrome, left bundle branch block, early repolarization,
early post-cardioversion, intracranial hemorrhage, and
rarely, tumor invasion of the heart 3,4,5,6.

However, ST-elevations may result from etiologies other
than acute ischemia, and can be secondary to other
acutely life-threatening pathologies or relatively benign,
subacute causes. For example, ventricular aneurysms
resulting from prior myocardial infarction and pericarditis
can result in ST-elevation on EKG. Intracranial hemorrhage
or stress (takotsubo) cardiomyopathy can also present
with ST-elevations, theorized to be the result of increased
catecholamines. Left ventricular hypertrophy, a sequela
of poorly controlled hypertension, can also lead to J point
elevations mimicking STEMI3,4.
Here we review a case of unusual ST-elevation in a patient
with oropharyngeal squamous cell carcinoma metastatic
to the heart.

CASE PRESENTATION
A 55 year old male with a history of hepatitis C cirrhosis,
hypertension, and squamous cell carcinoma of the
mouth status post resection and weekly cisplatin/
paclitaxel chemotherapy and postoperative radiation
therapy to the neck, with known diffuse metastases,
presented with confusion and generalized weakness. His
initial physical exam was significant for hyperpigmentation of his neck and decreased breath sounds bilaterally.
His laboratory values showed hypercalcemia with an
ionized calcium of 7.4 mg/dL (normal 4.5-5.3 mg/dL).
Additionally, he was found to have troponin T of 0.10 ng/
mL (normal <0.01 ng/mL) and EKG showed 1 to 5 mm
ST-elevation in V2-V6 (Figure 1). Of note, an EKG done
four days prior showed ST-elevation, though less
pronounced (Figure 2). Chest x-ray showed bilateral lung
nodules consistent with metastases and bilateral airspace
disease (Figure 3). Urine drug screen was negative.
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OUTCOME
Because of his hypercalcemia, the patient was administered
aggressive intravenous (IV) hydration and IV bisphosphonates. Given the concern for STEMI, a transthoracic
echocardiogram was performed immediately which
showed a 2.4 cm mass involving the epicardium and
myocardium of the left and right ventricular apices and an
ejection fraction of 75% without segmental wall motion
abnormalities (Figures 4 and 5). His serial troponin values
decreased to 0.09 ng/mL and 0.08 ng/mL over the next
twelve hours. Cardiology was consulted and deemed that
given the patient’s history, absence of specific cardiac
symptoms, prior ST-changes, and echo findings, the EKG
changes were likely due to metastatic disease rather than
acute coronary syndrome. One suspected etiology of the
ST changes was from his significant hypercalcemia.
However, after resolution of his hypercalcemia, the ST
elevations persisted on EKG. Interestingly, prior to the
patient’s diagnosis of metastatic disease, his EKG did not
show these ST changes (Figure 6). Furthermore, the
patient’s ST elevations persisted after correction of his
hypercalcemia. Further workup for his altered mental
status revealed diffuse brain metastases and a sternal
wound concerning for infection so he was started on
broad spectrum antibiotics. Despite optimal medical
therapy, he had worsening shortness of breath and
hemodynamic instability. Given his poor prognosis, the
family and health care providers agreed that a comfort
care approach would be consistent with his wishes. He
passed away two weeks after admission.

DISCUSSION
When evaluating for potential acute coronary syndrome in
the presence of ST-elevation on electrocardiogram,
myocardial ischemia should always be the first consideration,
as a delay in providing revascularization can prove
catastrophic. However, after acute coronary artery occlusion
or coronary plaque rupture secondary to atherosclerotic
disease have been ruled out, it is important to consider other
causes for myocardial injury. Malignancy with metastatic
involvement of the heart is a rare cause of ST-elevation7.

1

The Medicine Forum, Vol. 17 [2016], Art. 3

Though often clinically insignificant, the incidence of
cardiac involvement in patients with known malignancy is
estimated between 9.1% – 25.0% based on current
literature 8,9. Nearly all varieties of malignancy can
metastasize to the heart, the most common being
primary lung cancer, primary breast cancer, hematologic
malignancies, and malignant melanoma10. There are four
primary pathways by which tumors can invade the heart:
hematogenous spread, lymphatic spread, transvenous
extension, and direct extension.
The location of neoplastic metastasis typically dictates
the subsequent symptomatology. The most common
clinical manifestations of tumors extending to the
pericardium are pericarditis and pericardial effusions,
which can be further complicated by cardiac tamponade.
Malignant effusions may develop insidiously or rapidly,
and the risk of tamponade development is always present
regardless of the size of the effusion. In addition, small
metastases to the pericardium have rarely been shown to
cause constrictive pericarditis10.
The clinical picture that develops in the setting of
pericardial involvement is distinctly different from that of
epicardial, myocardial, or endocardial involvement. Case
reports from the literature describe episodes of both atrial
and ventricular arrhythmias, along with complete heart
block due to invasion of the cardiac conduction system.
Additionally, significant infiltration of metastatic disease
into the coronary arteries, or extrinsic compression from
metastases or tumor burden, can result in a clinical
scenario mimicking acute coronary syndrome in regards
to both patient symptoms and EKG changes8,10.
When a patient with a known malignancy presents with
the new onset of cardiac symptoms in the absence of
another clear diagnosis, it is paramount to consider and
work up the possibility of metastatic disease. EKG findings
in metastasis to the myocardium may reveal ST-elevations
in contiguous leads that are persistent and not evolving
and typically are not accompanied by ST-depression in
reciprocal leads. Furthermore, EKG involvement of the
pericardium may show signs of low voltage or electrical
alternans, suggesting possible effusion or diffuse ST
elevation suggesting pericarditis 10. However, more
definitive imaging is needed to complete a metastatic
work up. Echocardiogram will reveal the presence of
overt cardiac masses and also pericardial effusions and
tamponade physiology, but it should only compose part
of the work up. Cardiac computerized tomography (CT)
would reveal tumor extension from proximal anatomic
sites, and coronary CT would provide evaluation of
coronary vasculature. On positron emission tomography
(PET), metastases will often show increased metabolic
activity. Of note, cardiac MRI provides the best tissue
characterization of the myocardium and is often able to
identify metastases missed on both cardiac CT and
echocardiography12.
Management of these conditions depends on the clinical
symptoms at presentation. Cardiac tamponade merits
urgent intervention via placement of a pericardial drain
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and subsequent evaluation for local radiotherapy and
possible chemotherapy to reduce the metastatic burden.
The same is true for brady- or tachy-arrhythmias induced
by cardiac metastasis, though symptoms can be mitigated
by placement of a pacemaker or the use of anti-arrhythmic
medication, respectively. If cardiac metastases are leading
to coronary artery occlusion or compression causing
ischemic symptoms, urgent surgical resection, radiation
therapy, or coronary angiography should be considered.

KEY POINTS
• The differential for ST-elevation includes STEMI, stress
cardiomyopathy, pericarditis, myocarditis, left
ventricular aneurysm, coronary vasospasm, pulmonary
embolism, the Brugada syndrome, left ventricular
hypertrophy, left bundle branch block, early repolarization, hyperkalemia, and rarely, tumor invasion of the
heart3,4,5,6.
• The clinical context, ST morphology and distribution,
comparison with prior EKGs and echocardiogram can
help distinguish between etiologies of ST-elevation.
• Patients with known or suspected metastatic disease
who present with possible ischemic heart disease or
rhythm disturbance should undergo a prompt cardiac
workup beginning with EKG and echocardiography,
with further imaging if clinical suspicion of cardiac
involvement persists.
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Figure 1. EKG from admission showing 1-5mm ST-elevations in leads V2-V6.

Figure 2. EKG four days prior to admission showing less prominent ST elevations in V2-V5, compared
to admission to EKG.

Figure 6. EKG from before patient developed metastatic disease showing no ST-elevations.

17 52016
8 | The
Published
by Medicine
JeffersonForum,
DigitalVolume
Commons,

Figure 3. Single-view chest x-ray on admission showing multiple
round masses within both lungs, predominantly in the lower lung
fields. The largest measures approximately 4.6 x 2.5 cm in the
right base.

Figure 4. Echocardiogram showing 2.4cm mass at left and right
ventricular apex: parasternal long axis view.

Figure 5. Echocardiogram showing 2.4cm mass at left and right
ventricular apex: apical four chamber view.
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